Object-based three-dimensional X-ray imaging

A form of three-dimensional X-ray imaging, called Object 3-D, is introduced, where the relevant subject material is represented as discrete ‘objects’. The surface of each such object is derived accurately from the projections of its outline, and of its other discontinuities, in about ten conventional X-ray views, distributed in solid angle. This technique is suitable for many applications, and permits dramatic savings in radiation exposure and in data acquisition and manipulation. It is well matched to user-friendly interactive displays.     

双关节骨外固定器在老年桡骨远端复杂性骨折治疗中的应用

目的：探讨双关节骨外固定器治疗桡骨远端复杂性骨折的效果。方法：对16例老年人桡骨远端复杂性骨折采用手法闭合复位、双关节骨外固定器固定进行治疗。结果：随访8～38个月，骨折均获得良好的复位与固定，疗效较满意。结论：手法复位，双关节外固定器治疗桡骨远端复杂性骨折，可有效矫正畸形，重建桡腕关节的稳定，是一种微创、安全、疗效确切的治疗方法。     

经舟骨月骨周围脱位的诊断和治疗

目的 探讨经舟骨月骨周围脱位的诊断和治疗。方法 回顾性分析17例经舟骨月骨周围脱位病例，背侧型13例，掌侧型4例；新鲜损伤组10例中8例行撬拨复位成功，仅2例因舟骨对位不良接受手术治疗；陈旧性组7例中均接受手术，4例行开放复位内固定，3例行近排腕骨切除术。结果 采用Cooney评价标准，优11例，良3例，可1例，差2例，优良率82．35％。结论 经舟骨月骨周围脱位的早期治疗简单且疗效较好，而一旦误诊，则多数需手术治疗，且残留不同程度的功能障碍。提高对本病损伤机制、腕部体征和影像学特点的认识和了解，减少误诊。是提高本病预后的关键因素之一。     

The adaptation of the plaque reduction assay for measuring specific cytotoxic cells in limiting dilution cultures

The use of the original haemolytic plaque reduction technique to measure cytotoxic T lymphocytes (CTL) has been developed further as a rapid screening assay, particularly suitable for limiting dilution analyses. Using hybridoma cells as targets, the cytotoxicity has been measured by the loss of haemolytic plaque formation and by the reduction of the amount of haemolytic monoclonal antibody secreted from viable target cells into the assay supernatants. The assessment of large numbers of cytotoxic samples has been greatly facilitated by quantitating the amount of haemoglobin released in the assay with an automated microELISA multiscanner and by scoring visually using a modification of the spot test. Using these new techniques, relatively high frequency estimates of cytotoxic cell precursors in an allogeneic response (1 in 462 spleen cells) and an anti-fluorescein response (1 in 3970 spleen cells) were obtained.     

An “all-season” mammoplasty

A reduction mammoplasty must produce a reduction in volume, a natural lasting shape, and minimal residual scarring. Many attempts to achieve this goal have been developed in recent years. The author described, in 1970, a vertical technique achieving an important reduction and a good shape but with the appearance of the end of the vertical scar below the brassiere line. In 1977, the author [3] modified the technique by the adjunction of a small horizontal scar to eliminate the inconvenience of the visible part of the vertical scar. In this article the author describes his technique which appears to be suitable for most types of breast deformities.     

致肝损伤中药的减毒措施及肝损伤的中药防治作用

中药在疾病预防和治疗的过程中发挥重大作用,但部分中药在临床的长期应用过程中,给人体带来的不良反应也逐渐显现出来,肝损伤属于其中之一。肝损伤也是中药新药研发过程中作为临床安全用药的重要检查项目,已成为众多上市药物退出市场的重要原因。随着对中药临床用药安全性的关注增加,关于中药肝损伤研究日益增多,大多数研究集中于中药或者中药成分的肝脏损伤研究。为了提高中药的安全性,该文总结了部分致肝损伤中药的物质基础和机制及降低中药肝损伤的措施,包括减少给药剂量和疗程,改变给药途径,改变药物剂型,药物配伍和炮制等方法;此外该文还总结了防治各种诱导物诱发肝损伤的单体中药、中药复方和中药成分及防治肝损伤的生物效应和作用机制。结合现代致肝损伤中药的减毒研究,提出明确致肝损伤中药的安全剂量和“毒-效”界限,明确减毒措施的减毒机制及确定致肝损伤中药的毒性物质基础,为致肝损伤中药的临床应用提供安全性保障;结合中药防治肝损伤的研究,提出加强中药防治肝损伤的临床研究的同时,利用现代科学技术“从局部到整体”来阐释中药复方防治肝损伤的科学内涵,进而为临床防治肝损伤提供科学依据。     

High-Protein,Low-Glycaemic Meal Replacement Decreases Fasting Insulin and Inflammation Markers—A 12-Month Subanalysis of the ACOORH Trial

Lifestyle interventions, including meal replacement, are effective in the prevention and treatment of type-2-diabetes and obesity. Since insulin is the key weight regulator, we hypothesised that the addition of meal replacement to a lifestyle intervention reduces insulin levels more effectively than lifestyle intervention alone. In the international multicentre randomised controlled ACOORH (Almased Concept against Overweight and Obesity and Related Health Risk) trial, overweight or obese persons who meet the criteria for metabolic syndrome (n = 463) were randomised into two groups. Both groups received nutritional advice focusing on carbohydrate restriction and the use of telemonitoring devices. The intervention group substituted all three main meals per day in week 1, two meals per day in weeks 2–4, and one meal per day in weeks 5–26 with a protein-rich, low-glycaemic meal replacement. Data were collected at baseline and after 1, 3, 6 and 12 months. All datasets providing insulin data (n = 446) were included in this predefined subanalysis. Significantly higher reductions in insulin (−3.3 ± 8.7 µU/mL vs. −1.6 ± 9.8 µU/mL), weight (−6.1 ± 5.2 kg vs. −3.2 ± 4.6 kg), and inflammation markers were observed in the intervention group. Insulin reduction correlated with weight reduction and the highest amount of weight loss (−7.6 ± 4.9 kg) was observed in those participants with an insulin decrease > 2 µU/mL. These results underline the potential for meal replacement-based lifestyle interventions in diabetes prevention, and measurement of insulin levels may serve as an indicator for adherence to carbohydrate restriction.     

偶氮聚合物作为结肠靶向药物载体的研究进展

在人体消化道中,偶氮键仅能被结肠厌氧菌代谢的偶氮还原酶还原在耐断裂,偶氮聚合物可作为潜在的高定位性的结肠靶向药物缓释载体,根据合成方法和最终的释药方式,偶氮聚合物药物释放体系可分为水凝胶体系,胞衣体系和聚合物前药体系。